Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,075.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 3,775.00p
  • 52 Week Low: 1,835.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,113
  • Market Cap: £108.42m

Regulatory News

Posting of Annual Report and Notice of AGM 11-Nov-2025 07:00 RNS
Director Dealing 04-Nov-2025 16:12 RNS
Director Dealing 30-Oct-2025 07:00 RNS
Director Dealing 27-Oct-2025 15:53 RNS
Results for the year ended 30 June 2025 27-Oct-2025 07:00 RNS
Holding(s) in Company 13-Aug-2025 14:19 RNS
Director Dealing 28-Apr-2025 17:13 RNS
Exercise of Options and Issue of Equity 11-Apr-2025 07:00 RNS
Interim Results 31-Mar-2025 07:00 RNS
Director Dealing 24-Dec-2024 09:14 RNS
Result of AGM 06-Dec-2024 07:00 RNS
Holding(s) in Company 04-Dec-2024 15:34 RNS
Director/PDMR Shareholding 22-Nov-2024 15:56 RNS
Notice of AGM 08-Nov-2024 07:57 RNS
Director/PDMR Shareholding 31-Oct-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,075.00p
Change Today -25.00p
% Change -1.19 %
52 Week High 3,775.00p
52 Week Low 1,835.00p
Volume 2,113
Shares Issued 5.22m
Market Cap £108.42m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 20-Nov-2025

Time Volume / Share Price
16:04 38 @ 2,091.00p
15:50 47 @ 2,091.00p
15:49 181 @ 2,050.00p
15:24 256 @ 2,092.00p
14:33 181 @ 2,075.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page